Neal C Bradsher Lineage Cell Therapeutics, Inc. (LCTX) insider trading activity

LCTX Quotes by TradingView

Neal C Bradsher is Director of Lineage Cell Therapeutics, Inc.. Currently has a direct ownership of 87,628 shares of LCTX, which is worth approximately $56,081. The most recent transaction as insider was on Jun 25, 2021, when has been sold 24,720 shares (Common Shares) at a price of $2.2 per share, resulting in proceeds of $54,384. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 87.6K
0% 3M change
0% 12M change
Total Value Held $56,081

NEAL C BRADSHER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 25 2021
BUY
Exercise of conversion of derivative security
$54,384 $2.2 p/Share
24,720 Added 22.0%
87,628 Common Shares
NCB

Neal C Bradsher

Director
New York, NY

Track Institutional and Insider Activities on LCTX

Follow Lineage Cell Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LCTX shares.

Notify only if

Insider Trading

Get notified when an Lineage Cell Therapeutics, Inc. insider buys or sells LCTX shares.

Notify only if

News

Receive news related to Lineage Cell Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LCTX